Condensed heteroaryl derivatives
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ASTELLAS PHARMA INC
- Publication Date
- 2003-06-25
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The present invention relates to fused heteroaryl derivatives useful as pharmaceuticals, especially phosphatidylinositol 3-kinase (PI3K) inhibitors and anticancer agents. Background technique
[0002] Phosphatidylinositol (hereinafter referred to as "PI") is one of cell membrane phospholipids, which is known to play a role in intracellular information transmission. In particular, it is well understood that PI(4,5) diphosphate (PI(4,5)P2) is broken down by phospholipase C into diacylglycerol and inositol (1,4,5) triphosphate, causing Activation of protein kinase C and intracellular calcium mobilization [MJ Berridge et al., Nature, 312, 315, (1984), Y Nishizuka, Science, 225, 1365 (1984)].
[0003] On the other hand, in the second half of the 1980s, PI3K was identified as an enzyme that phosphorylates the 3-position of the PI-inositol ring [D Whitman et al., Nature, 332, 664 (1988)].
[0004] PI3K was once thought to be a single enzyme when it was firs...